 Krystal Biotech KRYS stock is rising higher on Monday thanks to positive results from a recent Phase 3 clinical trial of VYJUVEK. The post KRYS Stock Alert: The Study Results That Have Krystal Biotech Rocketing 118 Today appeared first on InvestorPlace. 